CES

CES 2025 Roundup: AI-Powered Cameras Detect Asthma, COPD, Diabetes; Spit Reveals Stress Hormone Levels; Perimenopause Symptoms Revealed

 
• By 

In this first of a two-part series from CES, Medtech Insight tunes into two companies that developed AI-powered cameras to detect respiratory diseases and chronic diseases respectively, two companies offering at-home testing for cholesterol, and a saliva test to help detect symptoms of perimenopause.

CES 2025: Neurotech Thought Leaders, Innovators Discuss Future Of AI-Driven EEG Headphones, Neural Earbuds To Monitor Brain Health, Diagnose Disease

 
• By 

Medtech Insight brings you the highlights from two panel discussions at CES 2025 featuring innovators in the neurotech space discussing opportunities, challenges and ethical considerations in developing AI-driven solutions for the brain, and what lies ahead.

CES 2025: Ever-Growing Digital Health Programming Brings DTx, Smart Homes, AI, AgeTech, Home Health, Wearables To Venetian

 
• By 

Medtech Insight spoke with René Quashie, vice president of digital health at the Consumer Technology Association (CTA), about what to expect at this year’s CES show.

Pickleball, Smart Homes, Brain Games, Caregiving AgeTech Take Centerstage At AARP’s CES 2025 Presence

 
• By 

AARP returns to CES 2025 with pickleball court, 13,000-square-foot booth, up to 30 start-ups in AgeTech Collaborative showcasing innovations for brain health, active living, caregiver solutions, programming, and more.


Digital Health Roundup: CES Biggest Hits; Apple Versus Masimo; Insulet Recalls Diabetes App

 

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights interviews with industry leaders in medtech and healthtech and demos of some of the most innovative tech seen at CES 2024 in Las Vegas. Hannah Daniel dives into the latest developments in the intellectual property dispute between Apple and Masimo over blood oxygen sensors in the newer Apple Watch models.

Dexcom COO On Stelo CGM Plans, Apple Watch Developments, And Why Non-Invasive Glucose Monitoring Still Leaves Much To Desire

 
• By 

Exec Chat: Dexcom’s COO Jake Leach joined a panel discussion on the future of biosensing at CES 2024, where biowearables and glucose tech ranked among hot topics. He also spoke to Medtech Insight about plans for the company’s new CGM called Stelo, designed for people with type 2 diabetes who do not use insulin, Dexcom’s work with Apple to enable CGM users, and non-invasive monitoring prospects.

CES Roundup: Holoportation, Empathic Robot, Aging Suit, Bionic Prosthetic Arm, Headband For Better Sleep

 
• By 

In this second roundup from CES, Medtech Insight shines the light on Proto Hologram’s many use cases in health care, Intuition Robotics’ ElliQ robot to help the elderly feel less lonely, MIT AgeLab’s Aging Suit, Siemens/Unlimited Tomorrow’s partnership on a bionic prosthetic arm, and Earable Neuroscience’s Frenz Brainband to promote better sleep.

Roundup: AI-Powered Assistive Hearing Devices Scream With Personalization; Femtech From Baby Makers To Menopause

 
• By 

In this first of a two-part roundup from CES, Medtech Insight tunes into two companies that developed assistive hearing devices, OrCam Hear and Concha Labs, and three women’s health companies focusing on menopausal symptoms and an app to track the “baby-making” journey. 


Preview Of HealthTech At CES 2024: MagicMirror Of Health; Hologram Surgeon; Loud Whispers

 
• By 

At CES Unveiled, which offered members of the media a preview of the latest tech to be presented during the upcoming CES 2024 extravaganza, Medtech Insight spoke with leaders at Nuraologix, Holoconnects and Whispp about their technologies and plans.

Freshest In Agetech Headed For CES 2024: Meet Your Life-Size Hologram, Experience Being 80, Visit A (Really) Smart Home

 
• By 

AARP is putting AgeTech squarely on the map at CES 2024 with the largest booth at Sands Expo Convention Center, featuring 21 start-ups, 26 sessions, live improv, and demos.